How to better exploit the full potential of nanomedicines?

Combining in-depth knowledge of various nanomedicine platforms like LNPs or liposomes with state-of-the-art and fully automated equipment to formulate and screen large nanomedicine libraries, Nanoworx can significantly accelerate the journey from initial concept to optimized product ready for the clinic.

Nanoworx was founded in late 2024 to allow university groups, start-ups, as well as smaller and larger pharmaceutical companies to have access to nanomedicine expertise and infrastructure without having to make large upfront investments in equipment and staff. Set-up within the National Growth Fund program PharmaNL and with support from the TU/e, PivotPark, and ZonMW, Nanoworx has established a fully operational and validated lab to automatically generate and screen nanomedicine libraries. Such library can be produced in a fraction of the time and with great reproducibility compared to conventional techniques. The techniques employed by Nanoworx are fully scalable.